Measurement of Residual Disease for improved oncology trial outcomes - what factors make an MRD test most effective plus explore the pros and cons of various MRD measurement approaches.
Exploring the challenges with the diverse clinical biomarker requirements.
Over-encapsulation is a widely accepted blinding mechanism used throughout the clinical supplies industry, and while the process itself may appear relatively straightforward, packaging for clinical supplies is a complex process that is strictly controlled by Good Manufacturing Practices (GMP).
Understand the challenges value-based care will present, along with success strategies for transforming them into opportunities for innovation and increased market share.
How and why leading institutions have made the decision to switch from reliance on just one external IRB to partnering with multiple independent IRBs.
How to ensure participant materials are the most effective, useful, and compliant they can be.
Navigate the process of EDC vendor selection and make a better-informed purchase decision on this key technology for clinical research.
Applying lessons learned to the future of Immuno-oncology.
How automating site grant payments can optimize payment processes for sites leading to greater site satisfaction and allowing sites to operate at peak performance and reduce errors.
Vendor-selection processes are tilting toward finding as broad and deep a fit as possible, the better to capture the efficiencies from scale and repeatability that those moves are intended to deliver.
|
|
|
|
|
|
|
|
|